CALITHERA BIOSCIENCES, INC. CALA Balance Sheet

Calithera biosciences, inc. (CALA)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Dec'13
Assets
Current assets:
Cash and cash equivalents
40,467	60,437	21,661	76,792	40,584	51,058	61,135	55,870	54,841	48,475	39,411	57,997	89,072	10,601	11,600	7,326	12,166	6,105	8,431	11,319	73,877	101,969	34,852	33,820
Short-term investments
94,637	96,924	111,933	76,420	76,415	85,095	80,321	85,544	96,123	115,318	126,202	108,234	66,255	41,180	44,671	53,054	54,026	63,823	73,456	-	-	-	-	-
Receivables from collaborations
976	482	1,712	1,740	2,513	1,997	1,809	2,511	1,824	1,142	2,177	2,303	13,550	-	-	-	-	-	-	-	-	-	-	-
Short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	66,382	14,705	-	-	-
Prepaid expenses and other current assets
1,796	1,953	1,492	1,526	1,686	2,102	1,553	1,513	3,024	2,732	4,263	1,853	1,805	1,780	1,616	1,915	2,346	2,567	1,796	1,700	1,728	1,894	1,398	349
Total current assets
137,876	159,796	136,798	156,478	121,198	140,252	144,818	145,438	155,812	167,667	172,053	170,387	170,682	53,561	57,887	62,295	68,538	72,495	83,683	79,401	90,310	103,863	36,250	34,169
Long-term investments
-	-	-	-	-	-	-	10,828	20,270	22,361	30,920	41,953	51,743	-	-	-	2,103	1,997	-	10,486	5,693	-	-	-
Other assets
558	280	361	284	632	569	845	638	402	228	758	325	130	290	76	34	-	281	-	-	-	-	2,561	-
Long-term investments
3,006	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
440	440	440	440	440	440	440	440	440	440	440	440	440	46	46	46	46	46	46	46	46	46	46	116
Property and equipment, net
900	992	1,106	1,214	1,339	1,464	1,571	1,631	1,660	1,759	1,372	977	913	899	915	854	875	931	801	816	824	861	785	559
Operating lease right-of-use asset
6,898	7,260	7,614	7,960	8,297	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total assets
149,678	168,768	146,319	166,376	131,906	142,725	147,674	158,975	178,584	192,455	205,543	214,082	223,908	54,796	58,924	63,229	71,562	75,750	84,530	90,749	96,873	104,770	39,642	34,844
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
739	2,052	713	1,259	1,612	1,247	517	1,115	2,169	1,072	1,260	410	600	398	1,265	1,446	1,050	562	565	923	559	693	879	150
Accrued and other liabilities
15,014	17,572	17,792	18,159	-	13,634	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued liabilities
-	-	-	-	16,332	-	10,088	9,533	10,356	8,938	7,146	5,007	4,227	4,055	3,480	3,248	2,980	3,271	5,192	3,298	2,962	3,428	3,243	1,194
Current portion of deferred revenue
-	-	-	-	-	-	-	-	-	29,017	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of deferred revenue
-	-	-	-	-	-	-	-	17,065	-	29,017	29,017	29,017	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities
15,753	19,624	18,505	19,418	17,944	14,881	10,605	10,648	29,590	39,027	37,423	34,434	33,844	4,453	4,745	4,694	4,030	3,833	5,757	4,221	3,521	4,121	4,122	1,344
Noncurrent operating lease liability
6,260	6,718	7,155	7,576	7,988	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, less current portion
-	-	-	-	-	-	-	-	-	2,028	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, less current portion
-	-	-	-	-	-	-	-	-	-	9,282	16,536	23,790	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	1,130	1,159	1,162	1,127	1,093	746	648	543	437	368	316	264	129	165	200	235	270	-	31
Other non-current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	13	13	13	-	-
Non-current liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	292	-
Total liabilities
22,013	26,342	25,660	26,994	25,932	16,011	11,764	11,810	30,717	42,148	47,451	51,618	58,177	4,890	5,113	5,010	4,294	3,962	5,935	4,434	3,769	4,404	4,414	1,375
Commitments and contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Convertible preferred stock, $0.0001 par value, no shares and 7,757 shares authorized as of December 31, 2014 and 2013, respectively; no shares and 7,689 shares issued and outstanding as of December 31, 2014 and 2013, respectively
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70,241	54,282
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000 shares authorized as of December 31, 2019 and 2018; no shares issued and outstanding as of December 31, 2019 and 2018
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	0	-	0
Common stock, $0.0001 par value, 200,000 shares authorized as of March 31, 2020, and December 31, 2019; 64,687 and 63,514 shares issued and outstanding as of March 31, 2020, and December 31, 2019, respectively
6	6	5	5	4	4	4	4	4	4	4	4	4	2	2	2	2	2	2	2	2	2	0	-
Additional paid-in capital
438,131	428,479	384,962	383,419	325,905	322,993	312,751	305,235	302,937	300,906	297,569	295,881	293,852	172,419	167,042	162,637	161,342	156,353	-	-	-	-	-	-
Additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	155,023	153,884	152,820	152,218	10,008	9,329
Accumulated deficit
-310,547	-286,101	-264,373	-244,080	-219,928	-196,170	-176,671	-157,823	-154,748	-150,333	-139,358	-133,287	-128,094	-122,502	-112,982	-104,438	-94,080	-84,498	-76,430	-67,530	-59,712	-51,854	-45,021	-30,142
Accumulated other comprehensive income
75	42	65	38	-7	-113	-174	-251	-326	-270	-123	-134	-31	-13	-4	18	4	-69	-	-41	-6	-	-	-
Receivables from sales under the ATM program (Note 6)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	247	-	-	-	-	-	-	-	-	-
Total stockholders’ equity
127,665	142,426	120,659	139,382	105,974	126,714	135,910	147,165	147,867	150,307	158,092	162,464	165,731	49,906	53,811	58,219	67,268	71,788	78,595	86,315	93,104	100,366	-35,013	-20,813
Total liabilities and stockholders’ equity
149,678	168,768	146,319	166,376	131,906	142,725	147,674	158,975	178,584	192,455	205,543	214,082	223,908	54,796	58,924	63,229	71,562	75,750	84,530	90,749	96,873	104,770	39,642	34,844